CAS No. : 1046045-61-7

Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000255
Molecular Formula:C18H19N3O2S2
Molecular Weight:373.49
Target:SREBP inhibitor
IC50:1 uM [1]
Price:Get quote
We match the lowest price on market.

Your information is safe with us.

Cat No:I000255
Cas No:1046045-61-7

FGH10019 is a novel sterol regulatory element-binding protein (SREBP) inhibitor with IC50 of 1 uM; 5–10 times lower than the IC50 of fatostatin (~10 μM).
IC50 value: 1 uM [1]
Target: SREBP inhibitor
FGH10019 is a methanesulfonamide derivative of fatostatin, exhibited the highest activity in a cell-based assay, and exhibited better in vitro and in vivo physicochemical properties than fatostatin or the other derivatives that were synthesized and evaluated. is the most appropriate molecule for further testing in animal models, and this testing is currently under way.

[1]. Kamisuki S, et al. Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins. J Med Chem. 2011 Jul 14;54(13):4923-7.

Recommended Products
  • CAS No. :20460-33-7
    Product Name:


    Cat No: R042283 View details
  • CAS No. :61448-03-1
    Product Name:


    Cat No: R042295 View details
  • CAS No. :78916-55-9
    Product Name:


    Cat No: R042310 View details
  • CAS No. :6380-24-1
    Product Name:


    Cat No: R042320 View details